Understanding Medications: What is the first line of treatment for PMDD?
•
4 min read
Premenstrual Dysphoric Disorder (PMDD) affects an estimated 1.8–5.8% of menstruating women, causing severe emotional and physical symptoms in the weeks leading up to their period. For those suffering from this condition, a key question is what is the first line of treatment for PMDD. Clinical guidelines overwhelmingly recommend Selective Serotonin Reuptake Inhibitors (SSRIs) as the primary pharmacological approach.
